Cita APA (7a ed.)

AM, S., KD, S., & B, B. (2020). Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy. Dove Medical Press.

Cita Chicago Style (17a ed.)

AM, Sigmund, Sahasrabudhe KD, y Bhatnagar B. Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy. Dove Medical Press, 2020.

Cita MLA (8a ed.)

AM, Sigmund, et al. Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy. Dove Medical Press, 2020.